125i brachytherapy Latest Research Papers

Mirabegron reduces urinary frequency and improves overactive bladder symptoms at 3 months after 125I-brachytherapy for prostate cancer: An open-labeled, randomized, non–placebo-controlled study

Urology ◽

10.1016/j.urology.2021.12.018 ◽

2021 ◽

Author(s):

Yasushi Nakai ◽

Nobumichi Tanaka ◽

Isao Asakawa ◽

Makito Miyake ◽

Satoshi Anai ◽

...

Keyword(s):

Prostate Cancer ◽

Overactive Bladder ◽

Controlled Study ◽

Urinary Frequency ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms ◽

125I Brachytherapy

Download Full-text

The Clinical Value of Computed Tomography (CT)-Guided 125I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy

Cancer Management and Research ◽

10.2147/cmar.s313438 ◽

2021 ◽

Vol Volume 13 ◽

pp. 5297-5307

Author(s):

Zhanwang Xiang ◽

Zhihui Zhong ◽

Luwen Mu ◽

Guohong Li ◽

Churen Zhou ◽

...

Keyword(s):

Computed Tomography ◽

Lung Cancer ◽

Small Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Clinical Value ◽

Ct Guided ◽

Concurrent Radiochemotherapy ◽

125I Brachytherapy

Download Full-text

Radiation dose rate variations in different measurement scenarios after prostate 125I brachytherapy

Brachytherapy ◽

10.1016/j.brachy.2021.06.147 ◽

2021 ◽

Author(s):

Takashi Hanada ◽

Atsunori Yorozu ◽

Riki Kikumura ◽

Toshio Ohashi ◽

Naoyuki Shigematsu

Keyword(s):

Radiation Dose ◽

Dose Rate ◽

Radiation Dose Rate ◽

125I Brachytherapy

Download Full-text

PO-0241 EAU eligibility criteria for exclusive 125I brachytherapy for intermediate risk prostate cancer

Radiotherapy and Oncology ◽

10.1016/s0167-8140(21)06400-8 ◽

2021 ◽

Vol 158 ◽

pp. S201-S202

Author(s):

S. Robin ◽

S. Chabaud ◽

A. Serre ◽

B. Bringeon ◽

S. Clippe ◽

...

Keyword(s):

Prostate Cancer ◽

Intermediate Risk ◽

Eligibility Criteria ◽

Risk Prostate Cancer ◽

125I Brachytherapy

Download Full-text

Dose-rate constant and air-kerma strength evaluation of a new 125I brachytherapy source using Monte Carlo

Brazilian Journal of Radiation Sciences ◽

10.15392/bjrs.v9i1a.1441 ◽

2021 ◽

Vol 9 (1A) ◽

Author(s):

Camila De Oliveira Primo

Keyword(s):

Monte Carlo ◽

Dose Rate ◽

Rate Constant ◽

Strength Evaluation ◽

Air Kerma ◽

125I Brachytherapy ◽

Brachytherapy Source

Download Full-text

CT-Guided 125I Brachytherapy in the Treatment of Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization: A Pilot Study

Cancer Management and Research ◽

10.2147/cmar.s305422 ◽

2021 ◽

Vol Volume 13 ◽

pp. 3317-3326

Author(s):

Xinjian Xu ◽

Yiwen Ding ◽

Tianfan Pan ◽

Feng Gao ◽

Xiangzhong Huang ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Pilot Study ◽

Transarterial Chemoembolization ◽

Ct Guided ◽

125I Brachytherapy

Download Full-text

Corrections for photons attenuation and scattering for the extrapolation chamber for measurement of air-kerma strength of 125I brachytherapy source

Journal of Instrumentation ◽

10.1088/1748-0221/16/03/p03028 ◽

2021 ◽

Vol 16 (03) ◽

pp. P03028

Author(s):

C. Liu ◽

M. Song ◽

Y. Liu ◽

H. Wang ◽

K. Wei ◽

...

Keyword(s):

Air Kerma ◽

125I Brachytherapy ◽

Extrapolation Chamber ◽

Brachytherapy Source

Download Full-text

Preparation of 125I brachytherapy seeds by iodinating carbon bars with a silver coating

Applied Radiation and Isotopes ◽

10.1016/j.apradiso.2020.109426 ◽

2021 ◽

Vol 167 ◽

pp. 109426

Author(s):

Zhong-Yong Li ◽

Hui-Bo Gao ◽

Wen-Hui Zhang ◽

Xue-Feng Zhang ◽

Lian-Ge Han ◽

...

Keyword(s):

Silver Coating ◽

125I Brachytherapy

Download Full-text

Surgery combined with 125I brachytherapy for treatment of carcinoma ex pleomorphic adenoma of the parotid gland

Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ◽

10.1016/j.oooo.2020.11.017 ◽

2020 ◽

Author(s):

Yan-Qi Ma ◽

Lei Zheng ◽

Ming-Wei Huang ◽

Shu-Ming Liu ◽

Xiao-Ming Lv ◽

...

Keyword(s):

Parotid Gland ◽

Pleomorphic Adenoma ◽

Carcinoma Ex Pleomorphic Adenoma ◽

125I Brachytherapy

Download Full-text

CT-guided 125I brachytherapy combined with chemotherapy for the treatment of unresectable or locally advanced pancreatic carcinoma

Diagnostic and Interventional Radiology ◽

10.5152/dir.2020.19371 ◽

2020 ◽

Author(s):

Ma Luo ◽

◽

Jiawen Chen ◽

Zhihui Zhong ◽

Fujun Zhang ◽

...

Keyword(s):

Pancreatic Carcinoma ◽

Locally Advanced ◽

Ct Guided ◽

Locally Advanced Pancreatic Carcinoma ◽

125I Brachytherapy ◽

Advanced Pancreatic Carcinoma

Download Full-text

125i brachytherapy
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Mirabegron reduces urinary frequency and improves overactive bladder symptoms at 3 months after 125I-brachytherapy for prostate cancer: An open-labeled, randomized, non–placebo-controlled study

The Clinical Value of Computed Tomography (CT)-Guided 125I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy

Radiation dose rate variations in different measurement scenarios after prostate 125I brachytherapy

PO-0241 EAU eligibility criteria for exclusive 125I brachytherapy for intermediate risk prostate cancer

Dose-rate constant and air-kerma strength evaluation of a new 125I brachytherapy source using Monte Carlo

CT-Guided 125I Brachytherapy in the Treatment of Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization: A Pilot Study

Corrections for photons attenuation and scattering for the extrapolation chamber for measurement of air-kerma strength of 125I brachytherapy source

Preparation of 125I brachytherapy seeds by iodinating carbon bars with a silver coating

Surgery combined with 125I brachytherapy for treatment of carcinoma ex pleomorphic adenoma of the parotid gland

CT-guided 125I brachytherapy combined with chemotherapy for the treatment of unresectable or locally advanced pancreatic carcinoma

Export Citation Format

125i brachytherapyRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Mirabegron reduces urinary frequency and improves overactive bladder symptoms at 3 months after 125I-brachytherapy for prostate cancer: An open-labeled, randomized, non–placebo-controlled study

The Clinical Value of Computed Tomography (CT)-Guided 125I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy

Radiation dose rate variations in different measurement scenarios after prostate 125I brachytherapy

PO-0241 EAU eligibility criteria for exclusive 125I brachytherapy for intermediate risk prostate cancer

Dose-rate constant and air-kerma strength evaluation of a new 125I brachytherapy source using Monte Carlo

CT-Guided 125I Brachytherapy in the Treatment of Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization: A Pilot Study

Corrections for photons attenuation and scattering for the extrapolation chamber for measurement of air-kerma strength of 125I brachytherapy source

Preparation of 125I brachytherapy seeds by iodinating carbon bars with a silver coating

Surgery combined with 125I brachytherapy for treatment of carcinoma ex pleomorphic adenoma of the parotid gland

CT-guided 125I brachytherapy combined with chemotherapy for the treatment of unresectable or locally advanced pancreatic carcinoma

125i brachytherapy
Recently Published Documents